Literature DB >> 19864476

Denmark14-230 clone as an increasing cause of pneumococcal infection in Portugal within a background of diverse serotype 19A lineages.

Sandra I Aguiar1, Francisco R Pinto, Sónia Nunes, Isa Serrano, José Melo-Cristino, Raquel Sá-Leão, Mário Ramirez, Hermínia de Lencastre.   

Abstract

Pneumococci of serotype 19A are increasingly found to be the cause of infection in various geographic regions. We have characterized the serotype 19A isolates (n = 288) found among pneumococci responsible for infections (n = 1,925) and pneumococci recovered from asymptomatic carriers (n = 1,973) in Portugal between 2001 and 2006. We show that despite the existence of serotype 19A clones that have a greater potential to cause invasive disease or an enhanced colonization capacity, the lineage that is increasing as a cause of infection in Portugal is a multiresistant clone that is competent at both. The expanding Denmark(14)-230 clone found in Portugal is disseminated in other Mediterranean countries, where it is also increasingly responsible for invasive infections in both children and adults. The lineages driving the rise of serotype 19A infections in Asia and the United States (sequence type 320 [ST320] and ST199) are either absent or account for only a small proportion of isolates in Portugal. These data highlight the importance of locally circulating clones with the ability to compete in the nasopharyngeal niche in the emergence of the serotype 19A lineages which are an increasing cause of infection in various geographic regions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19864476      PMCID: PMC2812288          DOI: 10.1128/JCM.00665-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  35 in total

1.  Properties of novel international drug-resistant pneumococcal clones identified in day-care centers of Lisbon, Portugal.

Authors:  Natacha G Sousa; Raquel Sá-Leão; M Inês Crisóstomo; Carla Simas; Sónia Nunes; Nelson Frazão; João A Carriço; Rosario Mato; Ilda Santos-Sanches; Hermínia de Lencastre
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

2.  Natural history of drug-resistant clones of Streptococcus pneumoniae colonizing healthy children in Portugal.

Authors:  R Mato; I Santos Sanches; C Simas; S Nunes; J A Carriço; N G Sousa; N Frazão; J Saldanha; A Brito-Avô; J S Almeida; H de Lencastre
Journal:  Microb Drug Resist       Date:  2005       Impact factor: 3.431

3.  Illustration of a common framework for relating multiple typing methods by application to macrolide-resistant Streptococcus pyogenes.

Authors:  J A Carriço; C Silva-Costa; J Melo-Cristino; F R Pinto; H de Lencastre; J S Almeida; M Ramirez
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

4.  Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.

Authors:  Moe H Kyaw; Ruth Lynfield; William Schaffner; Allen S Craig; James Hadler; Arthur Reingold; Ann R Thomas; Lee H Harrison; Nancy M Bennett; Monica M Farley; Richard R Facklam; James H Jorgensen; John Besser; Elizabeth R Zell; Anne Schuchat; Cynthia G Whitney
Journal:  N Engl J Med       Date:  2006-04-06       Impact factor: 91.245

5.  Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States.

Authors:  Rekha Pai; Matthew R Moore; Tamara Pilishvili; Robert E Gertz; Cynthia G Whitney; Bernard Beall
Journal:  J Infect Dis       Date:  2005-11-01       Impact factor: 5.226

6.  Effect of the seven-valent conjugate pneumococcal vaccine on carriage and drug resistance of Streptococcus pneumoniae in healthy children attending day-care centers in Lisbon.

Authors:  Nelson Frazão; António Brito-Avô; Carla Simas; Joana Saldanha; Rosario Mato; Sónia Nunes; Natacha G Sousa; João A Carriço; Jonas S Almeida; Ilda Santos-Sanches; Hermínia de Lencastre
Journal:  Pediatr Infect Dis J       Date:  2005-03       Impact factor: 2.129

7.  Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.

Authors:  Rosalyn J Singleton; Thomas W Hennessy; Lisa R Bulkow; Laura L Hammitt; Tammy Zulz; Debby A Hurlburt; Jay C Butler; Karen Rudolph; Alan Parkinson
Journal:  JAMA       Date:  2007-04-25       Impact factor: 56.272

8.  Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

Authors:  Lauri A Hicks; Lee H Harrison; Brendan Flannery; James L Hadler; William Schaffner; Allen S Craig; Delois Jackson; Ann Thomas; Bernard Beall; Ruth Lynfield; Arthur Reingold; Monica M Farley; Cynthia G Whitney
Journal:  J Infect Dis       Date:  2007-10-04       Impact factor: 5.226

9.  Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine.

Authors:  Carmen Muñoz-Almagro; Iolanda Jordan; Amadeo Gene; Cristina Latorre; Juan J Garcia-Garcia; Roman Pallares
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

10.  Vaccine escape recombinants emerge after pneumococcal vaccination in the United States.

Authors:  Angela B Brueggemann; Rekha Pai; Derrick W Crook; Bernard Beall
Journal:  PLoS Pathog       Date:  2007-11       Impact factor: 6.823

View more
  23 in total

1.  Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype.

Authors:  Raquel Sá-Leão; Francisco Pinto; Sandra Aguiar; Sónia Nunes; João A Carriço; Nelson Frazão; Natacha Gonçalves-Sousa; José Melo-Cristino; Hermínia de Lencastre; Mário Ramirez
Journal:  J Clin Microbiol       Date:  2011-01-26       Impact factor: 5.948

2.  Serotype and clonal evolution of penicillin-nonsusceptible invasive Streptococcus pneumoniae in the 7-valent pneumococcal conjugate vaccine era in Italy.

Authors:  Giovanni Gherardi; Fabio D'Ambrosio; Daniela Visaggio; Giordano Dicuonzo; Maria Del Grosso; Annalisa Pantosti
Journal:  Antimicrob Agents Chemother       Date:  2012-07-02       Impact factor: 5.191

3.  Clonal evolution leading to maintenance of antibiotic resistance rates among colonizing Pneumococci in the PCV7 era in Portugal.

Authors:  Alexandra S Simões; Liliana Pereira; Sónia Nunes; António Brito-Avô; Hermínia de Lencastre; Raquel Sá-Leão
Journal:  J Clin Microbiol       Date:  2011-06-01       Impact factor: 5.948

4.  Molecular characterization of Streptococcus pneumoniae invasive serotype 19A isolates from adults in two Spanish regions (1994-2009).

Authors:  J M Marimón; M Alonso; D Rolo; C Ardanuy; J Liñares; E Pérez-Trallero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-08       Impact factor: 3.267

5.  Evolution of clonal and susceptibility profiles of serotype 19A Streptococcus pneumoniae among invasive isolates from children in Spain, 1990 to 2008.

Authors:  David Tarragó; Lorenzo Aguilar; Raquel García; María-José Gimenez; Juan-José Granizo; Asunción Fenoll
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

6.  Postvaccination increase in serotype 19A pneumococcal disease in Norway is driven by expansion of penicillin-susceptible strains of the ST199 complex.

Authors:  Didrik F Vestrheim; Martin Steinbakk; Ingeborg S Aaberge; Dominique A Caugant
Journal:  Clin Vaccine Immunol       Date:  2012-01-11

7.  Emergence of serotype 19A Streptococcus pneumoniae after PCV10 associated with a ST320 in adult population, in Porto Alegre, Brazil.

Authors:  M P Mott; J Caierão; G R Cunha; M M Del Maschi; K Pizzutti; P d'Azevedo; C A G Dias
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

8.  Is there a potential role for protein-conjugate pneumococcal vaccine in older adults?

Authors:  Iman Ridda; Daniel M Musher
Journal:  Australas Med J       Date:  2012-04-30

9.  Epidemiology of serotype 19A isolates from invasive pneumococcal disease in German children.

Authors:  Mark van der Linden; Ralf René Reinert; Winfried V Kern; Matthias Imöhl
Journal:  BMC Infect Dis       Date:  2013-02-05       Impact factor: 3.090

Review 10.  Clinical implications of pneumococcal serotypes: invasive disease potential, clinical presentations, and antibiotic resistance.

Authors:  Joon Young Song; Moon H Nahm; M Allen Moseley
Journal:  J Korean Med Sci       Date:  2013-01-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.